ADC Therapeutics Statistics
Total Valuation
ADCT has a market cap or net worth of $535.15 million. The enterprise value is $724.40 million.
Important Dates
The next confirmed earnings date is Tuesday, March 10, 2026, before market open.
| Earnings Date | Mar 10, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ADCT has 123.88 million shares outstanding. The number of shares has increased by 26.73% in one year.
| Current Share Class | 123.88M |
| Shares Outstanding | 123.88M |
| Shares Change (YoY) | +26.73% |
| Shares Change (QoQ) | +19.96% |
| Owned by Insiders (%) | 3.78% |
| Owned by Institutions (%) | 41.12% |
| Float | 97.69M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.67 |
| Forward PS | 6.16 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 9.63 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.63
| Current Ratio | 4.63 |
| Quick Ratio | 4.15 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.42 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -23.98% |
| Return on Invested Capital (ROIC) | -30.53% |
| Return on Capital Employed (ROCE) | -53.82% |
| Weighted Average Cost of Capital (WACC) | 12.05% |
| Revenue Per Employee | $283,808 |
| Profits Per Employee | -$629,966 |
| Employee Count | 265 |
| Asset Turnover | 0.24 |
| Inventory Turnover | 6.94 |
Taxes
In the past 12 months, ADCT has paid $1.10 million in taxes.
| Income Tax | 1.10M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +174.84% in the last 52 weeks. The beta is 1.97, so ADCT's price volatility has been higher than the market average.
| Beta (5Y) | 1.97 |
| 52-Week Price Change | +174.84% |
| 50-Day Moving Average | 3.82 |
| 200-Day Moving Average | 3.56 |
| Relative Strength Index (RSI) | 59.99 |
| Average Volume (20 Days) | 799,961 |
Short Selling Information
The latest short interest is 4.36 million, so 3.52% of the outstanding shares have been sold short.
| Short Interest | 4.36M |
| Short Previous Month | 3.83M |
| Short % of Shares Out | 3.52% |
| Short % of Float | 4.46% |
| Short Ratio (days to cover) | 6.45 |
Income Statement
In the last 12 months, ADCT had revenue of $75.21 million and -$166.94 million in losses. Loss per share was -$1.44.
| Revenue | 75.21M |
| Gross Profit | -43.18M |
| Operating Income | -122.55M |
| Pretax Income | -165.84M |
| Net Income | -166.94M |
| EBITDA | -121.50M |
| EBIT | -122.55M |
| Loss Per Share | -$1.44 |
Full Income StatementBalance Sheet
The company has $234.74 million in cash and $457.44 million in debt, with a net cash position of -$222.70 million or -$1.80 per share.
| Cash & Cash Equivalents | 234.74M |
| Total Debt | 457.44M |
| Net Cash | -222.70M |
| Net Cash Per Share | -$1.80 |
| Equity (Book Value) | -238.18M |
| Book Value Per Share | -2.11 |
| Working Capital | 225.11M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$131.90 million and capital expenditures -$354,000, giving a free cash flow of -$132.26 million.
| Operating Cash Flow | -131.90M |
| Capital Expenditures | -354,000 |
| Free Cash Flow | -132.26M |
| FCF Per Share | -$1.07 |
Full Cash Flow StatementMargins
Gross margin is -57.42%, with operating and profit margins of -162.94% and -221.97%.
| Gross Margin | -57.42% |
| Operating Margin | -162.94% |
| Pretax Margin | -220.51% |
| Profit Margin | -221.97% |
| EBITDA Margin | -161.55% |
| EBIT Margin | -162.94% |
| FCF Margin | n/a |
Dividends & Yields
ADCT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -26.73% |
| Shareholder Yield | -26.73% |
| Earnings Yield | -33.27% |
| FCF Yield | -26.36% |
Analyst Forecast
The average price target for ADCT is $7.50, which is 73.61% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $7.50 |
| Price Target Difference | 73.61% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 32.10% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ADCT has an Altman Z-Score of -7.8 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -7.8 |
| Piotroski F-Score | 3 |
